Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Преждевременные роды

Список литературы

  1. Romero R., Dey S.K., Fisher S.J. Preterm labor: one syndrome, many causes. Science. 2014; 345(6198):760–5.
  2. Rubens C.E., Sadovsky Y., Muglia L., Gravett M.G., Lackritz E., Gravett C. Prevention of preterm birth: harnessing science to address the global epidemic. Sci Transl Med. 2014; 6(262):262sr5.
  3. Savitz D.A., Terry J.W., Dole N., Thorp J.M., Siega-Riz A.M., Herring A.H. Comparison of pregnancy dating by last menstrual period, ultrasound scanning, and their combination. Am J Obstet Gynecol. 2002; 187(6):1660–6.
  4. Whitworth M., Bricker L., Mullan C. Ultrasound for fetal assessment in early pregnancy. Cochrane database Syst Rev. 2015; (7):CD007058.
  5. Romero R., Espinoza J., Kusanovic J.P., Gotsch F., Hassan S., Erez O., et al. The preterm parturition syndrome. BJOG. 2006; 113 Suppl:17–42.
  6. Ananth C. V, Vintzileos A.M. Medically indicated preterm birth: recognizing the importance of the problem. Clin Perinatol. 2008; 35(1):53–67, viii.
  7. Romero R., Miranda J., Chaiworapongsa T., Korzeniewski S.J., Chaemsaithong P., Gotsch F., et al. Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Reprod Immunol. 2014; 72(5):458–74.
  8. Gomez-Lopez N., Romero R., Panaitescu B., Leng Y., Xu Y., Tarca A.L., et al. Inflammasome activation during spontaneous preterm labor with intra-amniotic infection or sterile intra-amniotic inflammation. Am J Reprod Immunol. 2018; 80(5):e13049.
  9. Boyle A.K., Rinaldi S.F., Norman J.E., Stock S.J. Preterm birth: Inflammation, fetal injury and treatment strategies. J Reprod Immunol. 2017; 119:62–6.
  10. Kemp M.W. Preterm birth, intrauterine infection, and fetal inflammation. Front Immunol. 2014; 5:574.
  11. Keelan J.A. Intrauterine inflammatory activation, functional progesterone withdrawal, and the timing of term and preterm birth. J Reprod Immunol. 2018; 125:89–99.
  12. Ozalkaya E., Karatekin G., Topcuoğlu S., Gürsoy T., Ovalı F. Morbidity in preterm infants with fetal inflammatory response syndrome. Pediatr Int. 2016; 58(9):850–4.
  13. Myking S., Boyd H.A., Myhre R., Feenstra B., Jugessur A., Devold Pay A.S., et al. X-chromosomal maternal and fetal SNPs and the risk of spontaneous preterm delivery in a Danish/Norwegian genome-wide association study. PLoS One. 2013; 8(4):e61781.
  14. Strauss J.F., Romero R., Gomez-Lopez N., Haymond-Thornburg H., Modi B.P., Teves M.E., et al. Spontaneous preterm birth: advances toward the discovery of genetic predisposition. Am J Obstet Gynecol. 2018; 218(3):294-314.e2.
  15. Cao G., Liu J., Liu M. Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019. JAMA Pediatr. 2022; 176(8):787–96.
  16. Davey M.-A., Watson L., Rayner J.A., Rowlands S. Risk scoring systems for predicting preterm birth with the aim of reducing associated adverse outcomes. Cochrane database Syst Rev. 2011; 9;(11):CD0(11):CD004902.
  17. Ancel P.-Y., Lelong N., Papiernik E., Saurel-Cubizolles M.-J., Kaminski M., EUROPOP. History of induced abortion as a risk factor for preterm birth in European countries: results of the EUROPOP survey. Hum Reprod. 2004; 19(3):734–40.
  18. Younge N., Goldstein R.F., Bann C.M., Hintz S.R., Patel R.M., Smith P.B., et al. Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med. 2017; 376(7):617–28.
  19. WHO. Recommendations on Interventions to Improve Preterm Birth Outcomes. Geneva World Heal Organ. 2015; .
  20. Lykke J.A., Dideriksen K.L., Lidegaard O., Langhoff-Roos J. First-trimester vaginal bleeding and complications later in pregnancy. Obstet Gynecol. 2010; 115(5):935–44.
  21. Newman R.B., Goldenberg R.L., Iams J.D., Meis P.J., Mercer B.M., Moawad A.H., et al. Preterm prediction study: comparison of the cervical score and Bishop score for prediction of spontaneous preterm delivery. Obstet Gynecol. 2008; 112(3):508–15.
  22. Ehsanipoor R.M., Seligman N.S., Saccone G., Szymanski L.M., Wissinger C., Werner E.F., et al. Physical Examination-Indicated Cerclage: A Systematic Review and Meta-analysis. Obstet Gynecol. 2015; 126(1):125–35.
  23. Iams J.D., Cebrik D., Lynch C., Behrendt N., Das A. The rate of cervical change and the phenotype of spontaneous preterm birth. Am J Obstet Gynecol. 2011; 205(2):130.e1-6.
  24. Klein L.L., Gibbs R.S. Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth. Am J Obstet Gynecol. 2004; 190(6):1493–502.
  25. Laughon S.K., Albert P.S., Leishear K., Mendola P. The NICHD Consecutive Pregnancies Study: recurrent preterm delivery by subtype. Am J Obstet Gynecol. 2014; 210(2):131.e1-8.
  26. Saccone G., Perriera L., Berghella V. Prior uterine evacuation of pregnancy as independent risk factor for preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016; 214(5):572–91.
  27. Basso O., Olsen J., Christensen K. Low birthweight and prematurity in relation to paternal factors: a study of recurrence. Int J Epidemiol. 1999; 28(4):695–700.
  28. Boivin A., Luo Z.-C., Audibert F., Mâsse B., Lefebvre F., Tessier R., et al. Risk for preterm and very preterm delivery in women who were born preterm. Obstet Gynecol. 2015; 125(5):1177–84.
  29. Fuchs F., Monet B., Ducruet T., Chaillet N., Audibert F. Effect of maternal age on the risk of preterm birth: A large cohort study. PLoS One. 2018; 13(1):e0191002.
  30. Koike T., Minakami H., Kosuge S., Usui R., Matsubara S., Izumi A., et al. Uterine leiomyoma in pregnancy: its influence on obstetric performance. J Obstet Gynaecol Res. 1999; 25(5):309–13.
  31. Smith G.C.S., Wood A.M., Pell J.P., Dobbie R. Sudden infant death syndrome and complications in other pregnancies. Lancet (London, England). 2005; 366(9503):2107–11.
  32. Goisis A., Remes H., Martikainen P., Klemetti R., Myrskylä M. Medically assisted reproduction and birth outcomes: a within-family analysis using Finnish population registers. Lancet (London, England). 2019; 393(10177):1225–32.
  33. Dolgun Z.N., Inan C., Altintas A.S., Okten S.B., Sayin N.C. Preterm birth in twin pregnancies: Clinical outcomes and predictive parameters. Pakistan J Med Sci. 2016; 32(4):922–6.
  34. Schnarr J., Smaill F. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur J Clin Invest. 2008; 38 Suppl 2:50–7.
  35. Meis P.J., Michielutte R., Peters T.J., Wells H.B., Sands R.E., Coles E.C., et al. Factors associated with preterm birth in Cardiff, Wales. I. Univariable and multivariable analysis. Am J Obstet Gynecol. 1995; 173(2):590–6.
  36. Vinturache A.E., Gyamfi-Bannerman C., Hwang J., Mysorekar I.U., Jacobsson B. Maternal microbiome – A pathway to preterm birth. Semin Fetal Neonatal Med. 2016; 21(2):94–9.
  37. Esplin M.S., O’Brien E., Fraser A., Kerber R.A., Clark E., Simonsen S.E., et al. Estimating recurrence of spontaneous preterm delivery. Obstet Gynecol. 2008; 112(3):516–23.
  38. Hibbard J.U., Tart M., Moawad A.H. Cervical length at 16-22 weeks’ gestation and risk for preterm delivery. Obstet Gynecol. 2000; 96(6):972–8.
  39. Myra J., Roger H. Mayo Clinic Guide to a Healthy Pregnancy. HarperCollins Publishers; 2004.
  40. Alexander J.M., Mercer B.M., Miodovnik M., Thurnau G.R., Goldenberg R.L., Das A.F., et al. The impact of digital cervical examination on expectantly managed preterm rupture of membranes. Am J Obstet Gynecol. 2000; 183(4):1003–7.
  41. Oláh K.S., Gee H. The prevention of preterm delivery--can we afford to continue to ignore the cervix? Br J Obstet Gynaecol. 1992; 99(4):278–80.
  42. Divanovic E., Buchmann E.J. Routine heart and lung auscultation in prenatal care. Int J Gynaecol Obstet. 1999; 64(3):247–51.
  43. Sharif K., Whittle M. Routine antenatal fetal heart rate auscultation: is it necessary? J Obstet Gynaecol (Lahore). 1993; 13:111–3.
  44. Bond D.M., Middleton P., Levett K.M., van der Ham D.P., Crowther C.A., Buchanan S.L., et al. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks’ gestation for improving pregnancy outcome. Cochrane database Syst Rev. 2017; 3:CD004735.
  45. Cataño Sabogal C.P., Fonseca J., García-Perdomo H.A. Validation of diagnostic tests for histologic chorioamnionitis: Systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2018; 228:13–26.
  46. Bianchi-Jassir F., Seale A.C., Kohli-Lynch M., Lawn J.E., Baker C.J., Bartlett L., et al. Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017; 65(suppl_2):S133–42.
  47. Valkenburg-van den Berg A.W., Sprij A.J., Dekker F.W., Dörr P.J., Kanhai H.H.H. Association between colonization with Group B Streptococcus and preterm delivery: a systematic review. Acta Obstet Gynecol Scand. 2009; 88(9):958–67.
  48. Ting H.-S., Chin P.-S., Yeo G.S.H., Kwek K. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann Acad Med Singapore. 2007; 36(6):399–402.
  49. Ehsanipoor R.M., Swank M.L., Jwa S.C., Wing D.A., Tarabulsi G., Blakemore K.J. Placental α-Microglobulin-1 in Vaginal Secretions of Women with Evidence of Preterm Labor. Am J Perinatol. 2016; 33(2):208–13.
  50. Сorabian P. The ACTIMTM PARTUS versus THE TLIIQ ® SYSTEM as rapid response tests to aid in diagnosing preterm labour in symptomatic women. In: Institute of Health Economics, Canada. 2008.
  51. Alfirevic Z., Allen-Coward H., Molina F., Vinuesa C.P., Nicolaides K. Targeted therapy for threatened preterm labor based on sonographic measurement of the cervical length: a randomized controlled trial. Ultrasound Obstet Gynecol. 2007; 29(1):47–50.
  52. Palacio M., Kühnert M., Berger R., Larios C.L., Marcellin L. Meta-analysis of studies on biochemical marker tests for the diagnosis of premature rupture of membranes: comparison of performance indexes. BMC Pregnancy Childbirth. 2014; 14:183.
  53. Leitich H., Brunbauer M., Kaider A., Egarter C., Husslein P. Cervical length and dilatation of the internal cervical os detected by vaginal ultrasonography as markers for preterm delivery: A systematic review. Am J Obstet Gynecol. 1999; 181(6):1465–72.
  54. Berghella V., Palacio M., Ness A., Alfirevic Z., Nicolaides K.H., Saccone G. Cervical length screening for prevention of preterm birth in singleton pregnancy with threatened preterm labor: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol. 2017; 49(3):322–9.
  55. Norman J.E., Marlow N., Messow C.-M., Shennan A., Bennett P.R., Thornton S., et al. Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double-blind placebo-controlled trial (OPPTIMUM). Health Technol Assess. 2018; 22(35):1–304.
  56. Medley N., Poljak B., Mammarella S., Alfirevic Z. Clinical guidelines for prevention and management of preterm birth: a systematic review. BJOG. 2018; 125(11):1361–9.
  57. Campbell S. Prevention of spontaneous preterm birth: universal cervical length assessment and vaginal progesterone in women with a short cervix: time for action! Am J Obstet Gynecol. 2018; 218(2):151–8.
  58. Romero R., Conde-Agudelo A., Da Fonseca E., O’Brien J.M., Cetingoz E., Creasy G.W., et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol. 2018; 218(2):161–80.
  59. FIGO Working Group on Good Clinical Practice in Maternal-Fetal Medicine. Good clinical practice advice: Prediction of preterm labor and preterm premature rupture of membranes. Int J Gynaecol Obstet. 2019; 144(3):340–6.
  60. Bortoletto T.G., Silva T. V, Borovac-Pinheiro A., Pereira C.M., Silva A.D., França M.S., et al. Cervical length varies considering different populations and gestational outcomes: Results from a systematic review and meta-analysis. PLoS One. 2021; 16(2):e0245746.
  61. Mönckeberg M., Valdés R., Kusanovic J.P., Schepeler M., Nien J.K., Pertossi E., et al. Patients with acute cervical insufficiency without intra-amniotic infection/inflammation treated with cerclage have a good prognosis. J Perinat Med. 2019; 47(5):500–9.
  62. Kim C.J., Romero R., Chaemsaithong P., Kim J.-S. Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance. Am J Obstet Gynecol. 2015; 213(4 Suppl):S53-69.
  63. Beinlich A., Fischäss C., Kaufmann M., Schlösser R., Dericks-Tan J.S. Lamellar body counts in amniotic fluid for prediction of fetal lung maturity. Arch Gynecol Obstet. 1999; 262(3–4):173–80.
  64. Vogel J.P., Nardin J.M., Dowswell T., West H.M., Oladapo O.T. Combination of tocolytic agents for inhibiting preterm labour. Cochrane database Syst Rev. 2014; 11;(7):CD0(7):CD006169.
  65. Neilson J.P., West H.M., Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane database Syst Rev. 2014; (2):CD004352.
  66. Dodd J.M., Crowther C.A., Middleton P. Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane database Syst Rev. 2012; 12:CD003927.
  67. Flenady V., Wojcieszek A.M., Papatsonis D.N.M., Stock O.M., Murray L., Jardine L.A., et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane database Syst Rev. 2014; (6):CD002255.
  68. Naik Gaunekar N., Raman P., Bain E., Crowther C.A. Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour. Cochrane database Syst Rev. 2013; (10):CD004071.
  69. Lyell D.J., Pullen K.M., Mannan J., Chitkara U., Druzin M.L., Caughey A.B., et al. Maintenance nifedipine tocolysis compared with placebo: a randomized controlled trial. Obstet Gynecol. 2008; 112(6):1221–6.
  70. Jacquemyn Y., Van Overmeire B. Tocolytic therapy: a meta-analysis and decision analysis. Obstet Gynecol. 2009; 114(1):170–1; author reply 171.
  71. Sanchez-Ramos L., Kaunitz A.M., Gaudier F.L., Delke I. Efficacy of maintenance therapy after acute tocolysis: a meta-analysis. Am J Obstet Gynecol. 1999; 181(2):484–90.
  72. Desplanches T., Lejeune C., Cottenet J., Sagot P., Quantin C. Cost-effectiveness of diagnostic tests for threatened preterm labor in singleton pregnancy in France. Cost Eff Resour Alloc. 2018; 16:21.
  73. Hyagriv N., Simhan M., Caritis S. Inhibition of acute preterm labor. UpToDate.
  74. Haas D.M., Caldwell D.M., Kirkpatrick P., McIntosh J.J., Welton N.J. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ. 2012; 345:e6226.
  75. King J.F., Flenady V.J., Papatsonis D.N., Dekker G.A., Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane database Syst Rev. 2003; (1):CD0022(1):CD002255.
  76. Flenady V., Reinebrant H.E., Liley H.G., Tambimuttu E.G., Papatsonis D.N.M. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane database Syst Rev. 2014; (6):CD004452.
  77. Письмо Минздрава России от 17 декабря 2013г. №15-4\10\2-9480. Клинические рекомендации (протокол лечения) «Преждевременные роды».
  78. King J., Flenady V., Cole S., Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane database Syst Rev. 2005; 18;(2):CD0(2):CD001992.
  79. Ogawa K., Tanaka S., Limin Y., Arata N., Sago H., Yamamoto-Hanada K., et al. Beta-2 receptor agonist exposure in the uterus associated with subsequent risk of childhood asthma. Pediatr Allergy Immunol. 2017; 28(8):746–53.
  80. Crowther C.A., Brown J., McKinlay C.J.D., Middleton P. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane database Syst Rev. 2014; (8):CD001060.
  81. Han S., Crowther C.A., Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. In: Crowther CA, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2010.
  82. Doyle L.W., Crowther C.A., Middleton P., Marret S., Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane database Syst Rev. 2009; (1):CD0046(1):CD004661.
  83. Costantine M.M., Weiner S.J., Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol. 2009; 114(2 Pt 1):354–64.
  84. Elliott J.P., Lewis D.F., Morrison J.C., Garite T.J. In defense of magnesium sulfate. Obstet Gynecol. 2009; 113(6):1341–8.
  85. Bachnas M.A., Akbar M.I.A., Dachlan E.G., Dekker G. The role of magnesium sulfate (MgSO4) in fetal neuroprotection. J Matern Fetal Neonatal Med. 2021; 34(6):966–78.
  86. Kenyon S., Boulvain M., Neilson J.P. Antibiotics for preterm rupture of membranes. Cochrane database Syst Rev. 2013; (2):CD0010(12):CD001058.
  87. Kenyon S., Pike K., Jones D.R., Brocklehurst P., Marlow N., Salt A., et al. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet (London, England). 2008; 372(9646):1310–8.
  88. Lin L.-L., Hung J.-N., Shiu S.-I., Su Y.-H., Chen W.-C., Tseng J.-J. Efficacy of prophylactic antibiotics for preterm premature rupture of membranes: a systematic review and network meta-analysis. Am J Obstet Gynecol MFM. 2023; 5(7):100978.
  89. Seaman R.D., Kopkin R.H., Turrentine M.A. Erythromycin vs azithromycin for treatment of preterm prelabor rupture of membranes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022; 226(6):794-801.e1.
  90. Navathe R., Schoen C.N., Heidari P., Bachilova S., Ward A., Tepper J., et al. Azithromycin vs erythromycin for the management of preterm premature rupture of membranes. Am J Obstet Gynecol. 2019; 221(2):144.e1-144.e8.
  91. Pereira A.M.G., Pannain G.D., Esteves B.H.G., Bacci M.L. de L., Rocha M.L.T.L.F. da, Lopes R.G.C. Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysis. Einstein (Sao Paulo). 2022; 20:eRW0015.
  92. Feduniw S., Gaca Z., Malinowska O., Brunets W., Zgliczyńska M., Włodarczyk M., et al. The Management of Pregnancy Complicated with the Previable Preterm and Preterm Premature Rupture of the Membranes: What about a Limit of Neonatal Viability?-A Review. Diagnostics (Basel, Switzerland). 2022; 12(8).
  93. Practice Bulletin No. 199: Use of Prophylactic Antibiotics in Labor and Delivery: Correction. Obstet Gynecol. 2019; 134(4):883–4.
  94. Hofmeyr G.J., Eke A.C., Lawrie T.A. Amnioinfusion for third trimester preterm premature rupture of membranes. Cochrane database Syst Rev. 2014; (3):CD0009(3):CD000942.
  95. Alfirevic Z., Stampalija T., Medley N. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane database Syst Rev. 2017; 6:CD008991.
  96. Preterm labour and birth. NICE guideline NG25 (last updated 10 June 2022). London: National Institute for Health and Care Excellence (UK). 2015.
  97. Gupta M., Emary K., Impey L. Emergency cervical cerclage: predictors of success. J Matern Fetal Neonatal Med. 2010; 23(7):670–4.
  98. Aaronson J., Goodman S. Obstetric anesthesia: not just for cesareans and labor. Semin Perinatol. 2014; 38(6):378–85.
  99. Wortman M., Carroll K. Office-Based Gynecologic Surgery (OBGS): Past, Present, and Future: Part I. Surg Technol Int. 2019; 35:173–84.
  100. Chestnut D.H., Wong C.A., Tsen L.C., Kee W.D.N., Beilin Y., Mhyre J. Chestnut’s Obstetric Anesthesia: Principles and Practice, 5th Edition. Elsevier Science; 2014. 1304 p.
  101. Rahman A. Shnider and Levinson’s Anesthesia for Obstetrics, Fifth Edition. Anesthesiology. 2015; 122(1):223.
  102. L.Fleisher, Wiener-Kronish J. Miller’s Anesthesia, 9th Edition. Anesthesiology. 2019; .
  103. Ioscovich A., Popov A., Gimelfarb Y., Gozal Y., Orbach-Zinger S., Shapiro J., et al. Anesthetic management of prophylactic cervical cerclage: a retrospective multicenter cohort study. Arch Gynecol Obstet. 2015; 291(3):509–12.
  104. Wang Y.-Y., Duan H., Zhang X.-N., Wang S., Gao L. A Novel Cerclage Insertion: Modified Laparoscopic Transabdominal Cervical Cerclage with Transvaginal Removing (MLTCC-TR). J Minim Invasive Gynecol. 2019; .
  105. Rahkonen L., Unkila-Kallio L., Nuutila M., Sainio S., Saisto T., Rutanen E.-M., et al. Cervical length measurement and cervical phosphorylated insulin-like growth factor binding protein-1 testing in prediction of preterm birth in patients reporting uterine contractions. Acta Obstet Gynecol Scand. 2009; 88(8):901–8.
  106. Abou El Senoun G., Dowswell T., Mousa H.A. Planned home versus hospital care for preterm prelabour rupture of the membranes (PPROM) prior to 37 weeks’ gestation. Cochrane database Syst Rev. 2010; (4):CD0080(4):CD008053.
  107. Xu J., Zhou J., Xiao H., Pan S., Liu J., Shang Y., et al. A Systematic Review and Meta-Analysis Comparing Programmed Intermittent Bolus and Continuous Infusion as the Background Infusion for Parturient-Controlled Epidural Analgesia. Sci Rep. 2019; 9(1):2583.
  108. Mędrzycka-Dabrowska W., Czyż-Szypenbejl K., Pietrzak J. A review of randomized trials comparisons of epidural with parenteral forms of pain relief during labour and its impact on operative and cesarean delivery rate. Ginekol Pol. 2018; 89(8):460–7.
  109. Anim-Somuah M., Smyth R.M., Cyna A.M., Cuthbert A. Epidural versus non-epidural or no analgesia for pain management in labour. Cochrane database Syst Rev. 2018; 5:CD000331.
  110. Sng B.L., Zeng Y., de Souza N.N.A., Leong W.L., Oh T.T., Siddiqui F.J., et al. Automated mandatory bolus versus basal infusion for maintenance of epidural analgesia in labour. Cochrane database Syst Rev. 2018; 5:CD011344.
  111. Sng B.L., Leong W.L., Zeng Y., Siddiqui F.J., Assam P.N., Lim Y., et al. Early versus late initiation of epidural analgesia for labour. Cochrane database Syst Rev. 2014; (10):CD007238.
  112. Wang T.-T., Sun S., Huang S.-Q. Effects of Epidural Labor Analgesia With Low Concentrations of Local Anesthetics on Obstetric Outcomes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Anesth Analg. 2017; 124(5):1571–80.
  113. Magro-Malosso E.R., Saccone G., Di Tommaso M., Mele M., Berghella V. Neuraxial analgesia to increase the success rate of external cephalic version: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2016; 215(3):276–86.
  114. Gimovsky A.C., Guarente J., Berghella V. Prolonged second stage in nulliparous with epidurals: a systematic review. J Matern Fetal Neonatal Med. 2017; 30(4):461–5.
  115. Braga A. de F. de A., Carvalho V.H., Braga F.S. da S., Pereira R.I.C. [Combined spinal-epidural block for labor analgesia. Comparative study with continuous epidural block]. Rev Bras Anestesiol. 69(1):7–12.
  116. ACOG Practice Bulletin No. 209: Obstetric Analgesia and Anesthesia. Obstet Gynecol. 2019; 133(3):e208–25.
  117. Loubert C., Hinova A., Fernando R. Update on modern neuraxial analgesia in labour: a review of the literature of the last 5 years. Anaesthesia. 2011; 66(3):191–212.
  118. Alfirevic Z., Milan S.J., Livio S. Caesarean section versus vaginal delivery for preterm birth in singletons. Cochrane database Syst Rev. 2012; (6):CD0000(6):CD000078.
  119. Holzer I., Lehner R., Ristl R., Husslein P.W., Berger A., Farr A. Effect of delivery mode on neonatal outcome among preterm infants: an observational study. Wien Klin Wochenschr. 2017; 129(17–18):612–7.
  120. Bergenhenegouwen L.A., Meertens L.J.E., Schaaf J., Nijhuis J.G., Mol B.W., Kok M., et al. Vaginal delivery versus caesarean section in preterm breech delivery: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2014; 172:1–6.
  121. Grabovac M., Karim J.N., Isayama T., Liyanage S.K., McDonald S.D. What is the safest mode of birth for extremely preterm breech singleton infants who are actively resuscitated? A systematic review and meta-analyses. BJOG. 2018; 125(6):652–63.
  122. Morales R., Adair C.D., Sanchez-Ramos L., Gaudier F.L. Vacuum extraction of preterm infants with birth weights of 1,500-2,499 grams. J Reprod Med. 1995; 40(2):127–30.
  123. Miksovsky P., Watson W.J. Obstetric vacuum extraction: state of the art in the new millennium. Obstet Gynecol Surv. 2001; 56(11):736–51.
  124. Corcoran S., Daly N., Eogan M., Holohan M., Clarke T., Geary M. How safe is preterm operative vaginal delivery and which is the instrument of choice? J Perinat Med. 2013; 41(1):57–60.
  125. Mottet N., Riethmuller D. Mode of delivery in spontaneous preterm birth. J Gynecol Obstet Biol Reprod (Paris). 2016; 45(10):1434–45.
  126. Afolabi B.B., Lesi F.E.A., Merah N.A. Regional versus general anaesthesia for caesarean section. Cochrane database Syst Rev. 2006; (4):CD004350.
  127. Jing C., Wang C. Combining Spinal-Epidural Anesthesia versus Single-Shot Spinal Anesthesia for Cesarean Delivery: A Meta-Analysis of 5 Randomized Controlled Trials. Med Sci Monit. 2019; 25:2859–67.
  128. Ao L., Shi J., Bai Y., Zheng Y., Gan J. Effectiveness and safety of intravenous application of dexmedetomidine for cesarean section under general anesthesia: a meta-analysis of randomized trials. Drug Des Devel Ther. 2019; 13:965–74.
  129. Sng B.L., Han N.L.R., Leong W.L., Sultana R., Siddiqui F.J., Assam P.N., et al. Hyperbaric vs. isobaric bupivacaine for spinal anaesthesia for elective caesarean section: a Cochrane systematic review. Anaesthesia. 2018; 73(4):499–511.
  130. Bao Z., Zhou C., Wang X., Zhu Y. Intravenous dexmedetomidine during spinal anaesthesia for caesarean section: A meta-analysis of randomized trials. J Int Med Res. 2017; 45(3):924–32.
  131. Sobhy S., Zamora J., Dharmarajah K., Arroyo-Manzano D., Wilson M., Navaratnarajah R., et al. Anaesthesia-related maternal mortality in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Glob Heal. 2016; 4(5):e320-7.
  132. Simmons S.W., Dennis A.T., Cyna A.M., Richardson M.G., Bright M.R. Combined spinal-epidural versus spinal anaesthesia for caesarean section. Cochrane database Syst Rev. 2019; 10:CD008100.
  133. Chen Y., Liu W., Gong X., Cheng Q. Comparison of Effects of General Anesthesia and Combined Spinal/Epidural Anesthesia for Cesarean Delivery on Umbilical Cord Blood Gas Values: A Double-Blind, Randomized, Controlled Study. Med Sci Monit. 2019; 25:5272–9.
  134. Kawakita T., Reddy U.M., Landy H.J., Iqbal S.N., Huang C.-C., Grantz K.L. Neonatal complications associated with use of fetal scalp electrode: a retrospective study. BJOG. 2016; 123(11):1797–803.
  135. Brocato B., Holliday N., Whitehurst R.M., Lewis D., Varner S. Delayed Cord Clamping in Preterm Neonates: A Review of Benefits and Risks. Obstet Gynecol Surv. 2016; 71(1):39–42.
  136. Katheria A.C., Reister F., Hummler H., Essers J., Mendler M., Truong G., et al. LB 1: Premature Infants Receiving Cord Milking or Delayed Cord Clamping: A Randomized Controlled Non-inferiority Trial. Am J Obstet Gynecol. 2019; 220(1):S682.
  137. McCall E.M., Alderdice F., Halliday H.L., Vohra S., Johnston L. Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants. Cochrane database Syst Rev. 2018; 2:CD004210.
  138. Wyllie J., Bruinenberg J., Roehr C.C., Rüdiger M., Trevisanuto D., Urlesberger B. European Resuscitation Council Guidelines for Resuscitation 2015: Section 7. Resuscitation and support of transition of babies at birth. Resuscitation. 2015; 95:249–63.
  139. Trumello C., Candelori C., Cofini M., Cimino S., Cerniglia L., Paciello M., et al. Mothers’ Depression, Anxiety, and Mental Representations After Preterm Birth: A Study During the Infant’s Hospitalization in a Neonatal Intensive Care Unit. Front public Heal. 2018; 6:359.
  140. Welch M.G., Halperin M.S., Austin J., Stark R.I., Hofer M.A., Hane A.A., et al. Depression and anxiety symptoms of mothers of preterm infants are decreased at 4 months corrected age with Family Nurture Intervention in the NICU. Arch Womens Ment Health. 2016; 19(1):51–61.
  141. Roberts D., Brown J., Medley N., Dalziel S.R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane database Syst Rev. 2017; 3:CD004454.
  142. Magann E.F., Haram K., Ounpraseuth S., Mortensen J.H., Spencer H.J., Morrison J.C. Use of antenatal corticosteroids in special circumstances: a comprehensive review. Acta Obstet Gynecol Scand. 2017; 96(4):395–409.
  143. Melamed N., Shah J., Yoon E.W., Pelausa E., Lee S.K., Shah P.S., et al. The role of antenatal corticosteroids in twin pregnancies complicated by preterm birth. Am J Obstet Gynecol. 2016; 215(4):482.e1-9.
  144. Norman M., Piedvache A., Børch K., Huusom L.D., Bonamy A.-K.E., Howell E.A., et al. Association of Short Antenatal Corticosteroid Administration-to-Birth Intervals With Survival and Morbidity Among Very Preterm Infants: Results From the EPICE Cohort. JAMA Pediatr. 2017; 171(7):678–86.
  145. Been J. V, Degraeuwe P.L., Kramer B.W., Zimmermann L.J.I. Antenatal steroids and neonatal outcome after chorioamnionitis: a meta-analysis. BJOG. 2011; 118(2):113–22.
  146. Amiya R.M., Mlunde L.B., Ota E., Swa T., Oladapo O.T., Mori R. Antenatal Corticosteroids for Reducing Adverse Maternal and Child Outcomes in Special Populations of Women at Risk of Imminent Preterm Birth: A Systematic Review and Meta-Analysis. PLoS One. 2016; 11(2):e0147604.
  147. Peaceman AM S.Y.Z.L.H.K.W.R. Gestational age–specific risks vs benefits of multicourse antenatal corticosteroids for preterm labor. Am J Obstet Gynecol. 2013; 209(4):330.e1-330.e7.
  148. Crowther C.A., McKinlay C.J.D., Middleton P., Harding J.E. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane database Syst Rev. 2015; (7):CD0039(7):CD003935.
  149. Garite T.J., Kurtzman J., Maurel K., Clark R., Obstetrix Collaborative Research Network. Impact of a “rescue course” of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. Am J Obstet Gynecol. 2009; 200(3):248.e1-9.
  150. Gyamfi-Bannerman C., Son M. Preterm premature rupture of membranes and the rate of neonatal sepsis after two courses of antenatal corticosteroids. Obstet Gynecol. 2014; 124(5):999–1003.
  151. Murphy K.E., Hannah M.E., Willan A.R., Hewson S.A., Ohlsson A., Kelly E.N., et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet (London, England). 2008; 372(9656):2143–51.
  152. Asztalos E. V, Murphy K.E., Willan A.R., Matthews S.G., Ohlsson A., Saigal S., et al. Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr. 2013; 167(12):1102–10.
  153. Wapner R.J., Sorokin Y., Mele L., Johnson F., Dudley D.J., Spong C.Y., et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007; 357(12):1190–8.
  154. Gyamfi-Bannerman C., Thom E.A., Blackwell S.C., Tita A.T.N., Reddy U.M., Saade G.R., et al. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med. 2016; 374(14):1311–20.
  155. Norman J., Shennan A., Jacobsson B., Stock S.J., Simpson J.L., Bianchi A., et al. FIGO good practice recommendations on the use of prenatal corticosteroids to improve outcomes and minimize harm in babies born preterm. Int J Gynecol Obstet. 2021; 155(1):26–30.
  156. Russell N.J., Seale A.C., O’Driscoll M., O’Sullivan C., Bianchi-Jassir F., Gonzalez-Guarin J., et al. Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017; 65(suppl_2):S100–11.
  157. Flenady V., Hawley G., Stock O.M., Kenyon S., Badawi N. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane database Syst Rev. 2013; (12):CD000(12):CD000246.
  158. Romero R., Conde-Agudelo A., Rehal A., Da Fonseca E., Brizot M.L., Rode L., et al. Vaginal progesterone for the prevention of preterm birth and adverse perinatal outcomes in twin gestations with a short cervix: an updated individual patient data meta-analysis. Ultrasound Obstet Gynecol. 2022; 59(2):263–6.
  159. Conde-Agudelo A., Romero R. Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a systematic review and meta-analysis. Am J Obstet Gynecol. 2022; 227(3):440-461.e2.
  160. Roman A.R., Da Silva Costa F., Araujo Júnior E., Sheehan P.M. Rescue Adjuvant Vaginal Progesterone May Improve Outcomes in Cervical Cerclage Failure. Geburtshilfe Frauenheilkd. 2018; 78(8):785–90.
  161. Berghella V., Odibo A.O., To M.S., Rust O.A., Althuisius S.M. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol. 2005; 106(1):181–9.
  162. Jin Z., Chen L., Qiao D., Tiwari A., Jaunky C.D., Sun B., et al. Cervical pessary for preventing preterm birth: a meta-analysis. J Matern Fetal Neonatal Med. 2019; 32(7):1148–54.
  163. Arabin B., Alfirevic Z. Cervical pessaries for prevention of spontaneous preterm birth: past, present and future. Ultrasound Obstet Gynecol. 2013; 42(4):390–9.
  164. Sosa C.G., Althabe F., Belizán J.M., Bergel E. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane database Syst Rev. 2015; (3):CD003581.
  165. Di Mascio D., Magro-Malosso E.R., Saccone G., Marhefka G.D., Berghella V. Exercise during pregnancy in normal-weight women and risk of preterm birth: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2016; 215(5):561–71.
  166. Yost N.P., Owen J., Berghella V., Thom E., Swain M., Dildy G.A., et al. Effect of coitus on recurrent preterm birth. Obstet Gynecol. 2006; 107(4):793–7.
  167. Middleton P., Gomersall J.C., Gould J.F., Shepherd E., Olsen S.F., Makrides M. Omega-3 fatty acid addition during pregnancy. Cochrane database Syst Rev. 2018; 11:CD003402.
  168. Pérez-López F.R., Pasupuleti V., Mezones-Holguin E., Benites-Zapata V.A., Thota P., Deshpande A., et al. Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2015; 103(5):1278-88.e4.
  169. Czeizel A.E., Dudás I., Métneki J. Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final report. Arch Gynecol Obstet. 1994; 255(3):131–9.
  170. Prevention of Group B Streptococcal Early-Onset Disease in Newborns (Number 797 (Replaces Committee Opinion No. 782), 2020

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*